188 related articles for article (PubMed ID: 32938782)
1. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
Shelly S; Paul P; Bi H; Dubey D; Milone M; Sorenson EJ; Crum BA; Laughlin RS; Liewluck T; Mandrekar J; Pittock SJ; Zekeridou A; McKeon A; Harper MC; Mills JR; Klein CJ
Neurology; 2020 Dec; 95(22):e3002-e3011. PubMed ID: 32938782
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
Zekeridou A; McKeon A; Lennon VA
JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
[TBL] [Abstract][Full Text] [Related]
3. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.
Husain AM; Massey JM; Howard JF; Sanders DB
Ann N Y Acad Sci; 1998 May; 841():471-4. PubMed ID: 9668277
[No Abstract] [Full Text] [Related]
5. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
[TBL] [Abstract][Full Text] [Related]
6. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
[TBL] [Abstract][Full Text] [Related]
7. Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis.
Li X; Mao YT; Wu JJ; Li LX; Chen XJ
J Neuroimmunol; 2015 Apr; 281():35-7. PubMed ID: 25867465
[TBL] [Abstract][Full Text] [Related]
8. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
[TBL] [Abstract][Full Text] [Related]
9. Seronegative myasthenia gravis associated with malignant thymoma.
Richards J; Howard JF
Neuromuscul Disord; 2017 May; 27(5):417-418. PubMed ID: 28238572
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
11. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
12. LRP4-IgG service line testing in seronegative myasthenia gravis and controls.
Klein CJ; Beecher G; Lamb C; Naddaf E; Milone M; Liewluck T; Dubey D; Zekeridou A; Shelly S; Mills JR
J Neuroimmunol; 2022 Jul; 368():577895. PubMed ID: 35617719
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody profiles and neurological correlations of thymoma.
Vernino S; Lennon VA
Clin Cancer Res; 2004 Nov; 10(21):7270-5. PubMed ID: 15534101
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for the Exacerbation of Myasthenic Symptoms After Surgical Therapy for Myasthenia Gravis and Thymoma.
Kato T; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Nakatochi M; Yokoi K
Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):378-385. PubMed ID: 31518701
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
17. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
[No Abstract] [Full Text] [Related]
18. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.
Vernino S; Auger RG; Emslie-Smith AM; Harper CM; Lennon VA
Neurology; 1999 Oct; 53(6):1233-9. PubMed ID: 10522878
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
